Patients requiring pediatric palliative care for advanced heart disease in France: A descriptive study

C La Fay1, P Le Moine2, L Blanc3

  • 1ERRSPP PACA, Timone Children's Hospital, AP-HM, 264 rue Saint-Pierre, 13385 Marseille, France.

Insights

Pediatric palliative care (PPC) teams support children with advanced heart diseases (AHD), primarily for ethical reasons and home care. Interventions are holistic, emphasizing family support and care coordination.

Area of Science:

  • Pediatric Cardiology
  • Palliative Care Medicine

Background:

  • Pediatric palliative care (PPC) teams improve quality of life for children with life-limiting conditions.
  • Limited understanding exists regarding PPC interventions in advanced heart diseases (AHD).

Purpose of the Study:

  • To elucidate the timing, reasons, and nature of PPC team interventions for children with AHD.

Main Methods:

  • Retrospective nationwide survey of PPC teams in France.
  • Analysis of all patients referred for cardiologic conditions in 2019.

Main Results:

  • 18 AHD patients received PPC consultations; 6 had cardiomyopathy, 12 had congenital heart disease (CHD).
  • Referrals were mainly for ethical considerations (50%) and home-based care organization (28%).
  • PPC provided family support, home care, care coordination, and symptom management.

Conclusions:

  • Ethical considerations are a primary driver for PPC referral in AHD.
  • PPC interventions adopt a holistic care model.
  • Further development of prospective outcomes measurement and partnerships is recommended.
Abstract

Related Concept Videos

Continuing Care01:25

Continuing Care

Continuing care describes the variety of health, personal, and social services provided over a prolonged period. The need for continuing care is increasing because people are living longer. Many people do not have families or others to care for them. Continuing care is mainly for patients who are disabled, functionally dependent, or suffering from a terminal disease. It is available within institutional settings or in homes. Examples include nursing centers or facilities, assisted living,...
1.6K
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
194
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
85
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
71
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
62
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
56